CRL Charles River Laboratories

$175.10

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/6/2025

About Charles River Laboratories

Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.

Website: https://www.criver.com

Sector
TRADE & SERVICES
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1100682
Address
251 BALLARDVALE ST, WILMINGTON, MA, US
Valuation
Market Cap
$5.21B
P/E Ratio
530.25
PEG Ratio
3.40
Price to Book
1.50
Performance
EPS
$0.20
Dividend Yield
—
Profit Margin
0.55%
ROE
0.71%
Technicals
50D MA
$153.54
200D MA
$185.39
52W High
$254.15
52W Low
$91.86
Fundamentals
Shares Outstanding
49M
Target Price
$159.11
Beta
1.45

CRL EPS Estimates vs Actual

● Estimated
● Actual

CRL News & Sentiment

Oct 06, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Pediatrix Medical Group, Inc. ( MD ) Soars to 52-Week High, Time to Cash Out?
Pediatrix Medical Group (MD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Sep 12, 2025 • Zacks Commentary SOMEWHAT-BULLISH
CRL Stock Rises Following New Strategic Oncology Collaborations
Charles River shares rise after new collaborations with PICI and CHLA, boosting its oncology and cell therapy pipeline momentum.
Sep 09, 2025 • Benzinga SOMEWHAT-BULLISH
This Thomson Reuters Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Charles River ( NYSE:CRL ) , Dick's Sporting Goods ( NYSE:DKS )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Jefferies analyst David Windley upgraded Charles River Laboratories International, Inc.
Sep 04, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Is it the Right Time to Add CRL Stock to Your Portfolio Now?
Charles River's DSA growth, acquisitions and collaborations support momentum, but forex and macro headwinds weigh on its outlook.
Sep 02, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Danaher Gains From Business Strength Amid Persisting Headwinds
DHR posts gains in bioprocessing, biotech and diagnostics, while life sciences softness and high debt weigh.
Sep 01, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Charles River Stock May Benefit From Joining EASYGEN Consortium
CRL joins EASYGEN to speed CAR-T therapy delivery, which may boost patient access and investor sentiment.
Sentiment Snapshot

Average Sentiment Score:

0.110
50 articles with scored sentiment

Overall Sentiment:

Neutral

CRL Reported Earnings

Feb 12, 2025
Dec 31, 2024 (Pre market)
0.13 Surprise
  • Reported EPS: $2.66
  • Estimate: $2.53
  • Whisper: —
  • Surprise %: 5.2%
Nov 06, 2024
Sep 30, 2024 (Pre market)
0.16 Surprise
  • Reported EPS: $2.59
  • Estimate: $2.43
  • Whisper: —
  • Surprise %: 6.6%
Aug 07, 2024
Jun 30, 2024 (Pre market)
0.41 Surprise
  • Reported EPS: $2.80
  • Estimate: $2.39
  • Whisper: —
  • Surprise %: 17.1%
May 09, 2024
Mar 31, 2024 (Pre market)
0.2 Surprise
  • Reported EPS: $2.27
  • Estimate: $2.07
  • Whisper: —
  • Surprise %: 9.7%
Feb 14, 2024
Dec 31, 2023 (Pre market)
0.06 Surprise
  • Reported EPS: $2.46
  • Estimate: $2.40
  • Whisper: —
  • Surprise %: 2.5%
Nov 08, 2023
Sep 30, 2023 (Pre market)
0.35 Surprise
  • Reported EPS: $2.72
  • Estimate: $2.37
  • Whisper: —
  • Surprise %: 14.8%
Aug 09, 2023
Jun 30, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $2.69
  • Estimate: $2.64
  • Whisper: —
  • Surprise %: 1.9%
May 11, 2023
Mar 31, 2023 (Pre market)
0.19 Surprise
  • Reported EPS: $2.78
  • Estimate: $2.59
  • Whisper: —
  • Surprise %: 7.3%
Feb 22, 2023
Dec 31, 2022 (Pre market)
0.23 Surprise
  • Reported EPS: $2.98
  • Estimate: $2.75
  • Whisper: —
  • Surprise %: 8.4%

Financials